[Modification of the THAM effect with low molecular dextran].
D000136:Acid-Base Equilibrium / Q000187:drug effects*; D001639:Bicarbonates / Q000097:blood; D002245:Carbon Dioxide / Q000097:blood; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003911:Dextrans / Q000494:pharmacology* / Q000627:therapeutic use; D004487:Edema / Q000188:drug therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006993:Hypnotics and Sedatives / Q000506:poisoning; D014325:Tromethamine / Q000494:pharmacology* / Q000627:therapeutic use
D001639:Bicarbonates; D003911:Dextrans; D006993:Hypnotics and Sedatives; D014325:Tromethamine; D002245:Carbon Dioxide
Die Beeinflussung der THAM-Wirkung durch niedermolekulares Dextran.